The FDA posted to its site the observations made during an inspection of an AstraZeneca (AZN) manufacturing center that was conducted from May ...
The $160 million acquisition of a FibroGen subsidiary expands AstraZeneca’s foothold in China while the company works through ...
AstraZeneca (AZN) is set to acquire U.S. biotech company FibroGen’s (FGEN) China unit for $160 million to expand its presence in the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback